Skip to main
GOVX
GOVX logo

Geovax Labs (GOVX) Stock Forecast & Price Target

Geovax Labs (GOVX) Analyst Ratings

Based on 9 analyst ratings
Strong Buy
Strong Buy 78%
Buy 22%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Geovax Labs Inc. is positioned favorably due to its active engagement in developing innovative vaccines and immunotherapies, specifically its key pipeline asset, the GEO-CM04S1 next-generation COVID-19 vaccine. The company is set to capitalize on government funding aimed at accelerating vaccine development, particularly in response to global health threats such as Ebola and Monkeypox, which may increase the importance of its research programs. Additionally, Geovax's strategy to enhance vaccine accessibility and strengthen domestic manufacturing capabilities aligns with a growing focus on establishing a diversified global vaccine supply chain, potentially enhancing its market viability and financial performance.

Bears say

Geovax Labs Inc faces a negative outlook due to the high cost of its preferred COVID-19 vaccine, which at $270 per dose presents significant barriers to widespread vaccination and exacerbates global access inequalities. Delays in distribution, limited production capacity, and reliance on a single supplier increase the risk of supply chain disruptions, particularly as demand from African health agencies remains unmet with only a fraction of requested doses anticipated. Additionally, the ongoing logistical and political challenges hinder effective vaccine distribution, contributing to unused stockpiles and signifying an inadequate global response to contain the virus.

Geovax Labs (GOVX) has been analyzed by 9 analysts, with a consensus rating of Strong Buy. 78% of analysts recommend a Strong Buy, 22% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Geovax Labs and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Geovax Labs (GOVX) Forecast

Analysts have given Geovax Labs (GOVX) a Strong Buy based on their latest research and market trends.

According to 9 analysts, Geovax Labs (GOVX) has a Strong Buy consensus rating as of Jun 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $10.67, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $10.67, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Geovax Labs (GOVX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.